{"references": ["Dispenzieri A.and Gorevic P 1999.Cryoglobulinemia.Haematol Oncol. Clin.Nort.Am.13(6);13125-1349.", "VermeerschP.,GijbelsK.,MarienG,LunnR,EgnerW,andBossuytX.2008.A critical Appraisal of current practice in detection,analysis and reporting of cryoglobulin.Clin.Chem.54:39-43.", "Ferri C.2008.Mixed cryoglobulinemia .Orphanet J Rare.Dis.3;251", "Ferri C., Zignego A.L .and Pileri S.A.2002 Cryoglobulins J.Clin.Pathol.55:4-13.", "Gorevic P. 2012.Rheumatoid factor ,complement and mixed cryoglobulinemia .Clin.Dev.Immunol. 201 ;1-\u00ac\u00ac6.", "Shnawa I.M.S.and Algebori N.R.R.2012.Circulatory and local cryoglobulinemia in tuberculus patients Baby.Uni.J.20(5):1419-1427.", "Shnawa I.M.S.and Algherani I.F.2014 .The effect of ageing on cryoglobulin responses in tuberculus patients.Baby.Uni.J.", "Shnawa IMS and Jasim YA 2011.BCG andTuberculin induced experimental lapin Secondary cryoglobulinemia. Qadisiah .Medical Journal. 7(12):209-219.", "Delgado S., Bravo L .and Gotuzzo E.2008.Mixed cryoglobulinemia due to brucellosis, Clin.Infect.Dis 47(3);435-436.\n[10]\tTicse R.,Varela L.,Barroval et al 2007.Mixed cryglobulinemia syndrome due to Brucellosis Rev.Med.Hered.18:34-3 \n[11]\tYoung E.A.2001.Immunology of brucellosis. In,Madkour M M eds,Madkours Brucellosis.Spriger,London,39-50.\n[12]\tShnawa I.M.S.and ALSerhan A.J.2014.Pathogenic potentials of Salmonella typhi human and rabbit cryoglobulins in a lapin model.Intr.Res.J.Biol.Sci.3(6):Impress.\n[13]\tGalli M.,Monti G.,Cereda U.G.DelGiudice G. ,Fiorenza A.M. and Invernizzi F.1984.Transient symptomatic cryoglobulinemia in gram negative bacterial infections Boll 1st Sieroter Milan63(1):57-60.\n[14]\tEldar M.,Neeman A.,Shoenfeld Y.andPinklas J.1980.Transient mixed cryoglobulinemia associated with typhoid hepatitis.New Istabul Contribution Clin.Sci. 13(1):55-57.\n[15]\tCruze J.M.2010.Atlas of Immunology,3rd.ed.CRCPress Taylar and FranciesU.K.,587.\n[16]\tBerg J.M.,Tymoczko J.L.and StryerL.2011.Biochemistry.International edtion Von Palgrave,Macmillian.\n[17]\tParslow TG,Stites D.P.,Terr A.I.and Imboden J.B.2001.Medical Immunology,10th ed.Lange Medical books,New York.\n[18]\tJaleel A.,Owen B.A.,Katzman J.A.,Kyle R.A.and Abraham R.S.2006.Bence Jones cryoglobulinemia.Clin.Chem.52(7):1435-1436.\n[19]\tUeda K.,Nakagawa T.,Shimizu A.,Nakagima H.and Ohsawa N.1997.Rheumatoid factor in the serum of hepatitis C virus-infected patients,an increase in the titre during cold storage.Ann.Clin.Biochem.33:438-442.\n[20]\tNamura H.O. ,Ogo T. ,Rikimaru N. et al.1997.Hepatitis C virus related liver damage is related to cold activation of complement. J.Gasteroenterol.25:529-534.\n[21]\tKallemunchikkas U .and Gorevic P.D.1999.Evaluation of cyoglobulins. Arch. Pathol.\t Lab.Med.23:119-125.\n[22]\tMorra E.2005.Cryoglobulinemia.Haematology,Am.Soc.Haematol.Education programme,free I ;368-372.\n[23]\tMotyckova G. and Murali M.2011.Laboratory testing for cryoglobulimemia. Am.J.Haematol 8\n[24]\tSchubert S.2010.Urinary tract immunology UrologeA 49(5):606-6011.\n[25]\tKrejsek J,Kudlova M., Kolakova M.and Novosad J.2008.Mucosal immunity with emphasis on urinary tract immunity and diabetes. Vintr Lek.54(5):478-481.\n[26]\tTheodorus K. 2011.Urinary tract immunology .Chapter 8 in, Clinical triel of complicated urinary tract infection. www.intechopen.\n[27]\tShnawa I.M.S. and AlSadi M.K.A.2001.Gut mucosal immunoglobulin: Separation, partial characterization an utility as infection probe Irq.J.Microbiol.13(3):57-70.\n[28]\tLynch P.M.L.2006.Audit cryoglobulin determination in Northren Irland. The Irland Regional Audit group, cryoglobulin subcommittee, Guidelines.\n[29]\tRamos-Casals M.,Stone J.H.,Cid M.C. and Bosch X. 2012.The cryoglobulinemias. Seminars Lancet 379:448-460.\n[30]\tSargur R., White P. and Egner W.2010.Cryoglobulin evaluation ,best practice.Ann.Clin.Biochem.47:8-16.\n[31]\tShnawa I.M.S.,Almammori R.T.O.and Mohammed G.J.2013.The assessment of IL12+P40 among primary pulmonary and chronic old pulmonary tuberculosis.Int.Res.J.Biol.Sci.2(12): \n[32]\tAlsaadi MAK,Shnawa IMS and Almukhtar S.2004.An evaluation study of cellular immune functions in anergic tuberculus patients. Med.J.Baby.4(3,40:198-204"]}

The procedure for the assessment of the urinary mucosal cryoglobulin (UMCG) is being reviewed, testified and evaluated. The major features of UMCG are rather similar to that of serum cryoglobulin. Such evident similarities are forming the reality for the existence of the UMCG. There were seven characterizing criteria useable for the identification for UMCG. Upon matching them to the Irish criteria for serum cryoglobulin, some modifications are being proposed to the 16th standards that has been formulated and built as an Irish criteria. The existence of UMCG is being reported for the first time in human chronic infectious bacterial disease.